TY - JOUR AU - Ilié, Marius AU - Hofman, Paul PY - 2016 TI - Pros: Can tissue biopsy be replaced by liquid biopsy? JF - Translational Lung Cancer Research; Vol 5, No 4 (August 29, 2016): Translational Lung Cancer Research Y2 - 2016 KW - N2 - In the past decade, ‘personalized’ or ‘stratified’ management based on the molecular features of tumors of patients with advanced non-small-cell lung cancer (NSCLC) has entered routine clinical practice. Identification on tumor tissue of predictive biomarkers of response to targeted treatments is now mandatory for optimal patient care, but faces several biological and technological challenges. UR - https://tlcr.amegroups.org/article/view/8950